Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Jun 16, 2013; 5(6): 288-292
Published online Jun 16, 2013. doi: 10.4253/wjge.v5.i6.288
Table 1 Baseline characteristics and cholangiographic findings of enrolled patients in both groups, including the comparison of procedural details, stone characteristics, and complications n (%)
DetailsTotal (n = 42)Success group(n = 37)Failed group(n = 5)P value
Male sex34 (81.0)6 (16.2)2 (40.0)NS
Age in years71.9 ± 14.271.9 ± 14.372.0 ± 15.5NS
Indications for ERC
Cholangitis22 (52.4)20 (54.1)2 (40.0)NS
Biliary pain10 (23.8)8 (21.6)2 (40.0)
Obstructive jaundice4 (9.5)3 (8.1)1 (20.0)
Acute pancreatitis2 (4.8)2 (5.4)0 (0.0)
Asymptomatic4 (9.5)4 (9.5)0 (0.0)
CBD size in mm1.83 ± 0.451.80 ± 0.442.06 ± 0.56NS
Stone size in mm1.86 ± 0.431.85 ± 0.412.04 ± 0.58NS
Stone number1.50 ± 1.061.51 ± 1.121.40 ± 0.55NS
Stone fit to CBD37 (88.1)32 (86.5)5 (100)NS
Stone shapeNS
Irregular7 (18.9)1 (20.0)
Geometric (oval, cube)30 (81.1)4 (80.0)
Stone characteristicsNS
Mixed stone17 (45.9)3 (60.0)
Cholesterol stone20 (54.1)2 (40.0)
Change in stone size
Decrease25 (67.6)1 (20.0)0.04
Stable12 (32.4)4 (80.0)
Balloon sphincteroplasty9 (24.3)3 (60.0)0.13
Use of mechanical lithotripsy14 (37.8)2 (40.0)NS
Time to successful procedures in weeks25.42 ± 40.42NoneNA
Sessions carried out2.43 ± 0.802.80 ± 1.30NS
Average follow-up time in months13.10 ± 13.7910.70 ± 8.81NS
Complications during follow-up periodNS
Ascending cholangitis6 (14.3)6 (16.2)0 (0.0)
Acute pancreatitis2 (4.8)1 (2.7)1 (20.0)
None34 (80.9)30 (81.1)4 (80.0)